Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

48.69

-0.77 (-1.56%)

At close: Apr 28, 2026, 4:00 PM EDT

47.69

-1.00 (-2.05%)

After-hours: Apr 28, 2026, 4:54 PM EDT

Supernus Pharmaceuticals Employees

Supernus Pharmaceuticals had 778 employees as of December 31, 2025. The number of employees increased by 104 or 15.43% compared to the previous year.

Employees

778

Change (1Y)

104

Growth (1Y)

15.43%

Revenue / Employee

$924,103

Profits / Employee

-$49,550

Market Cap

2.80B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	778	104	15.43%
Dec 31, 2024	674	22	3.37%
Dec 31, 2023	652	40	6.54%
Dec 31, 2022	612	37	6.43%
Dec 31, 2021	575	12	2.13%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Company Name	Employees
Bausch Health Companies	20,300
Amneal Pharmaceuticals	8,700
Perrigo Company	8,100
Phibro Animal Health	2,475
HUTCHMED (China)	1,796
ANI Pharmaceuticals	970
Prestige Consumer Healthcare	600
BioCryst Pharmaceuticals	435